Investors
Atlantis AI360 is not just another AI tool - it's a transformative platform reshaping how scientists, researchers, and healthcare professionals discover, collaborate, and commercialize knowledge. By fusing next-generation AI with a vertical marketplace for life sciences, Atlantis AI360 empowers users to generate documents, insights, and research outputs with unprecedented speed and precision - cutting months off the innovation cycle.
The explosion of biomedical data and the shortage of domain-aware AI solutions have created a massive gap in life sciences R&D productivity. Atlantis AI360 fills this void with a domain-specific, auto-learning engine tailored to biotech, pharma, and healthcare. With early validation from the life sciences industry leaders as well as Wall Street firms - we are already proving our impact and positioning ourselves as the "Google + LinkedIn + GitHub" for life sciences.
Our model is built for scale. Atlantis AI360 not only offers AI-generated knowledge assets but also hosts a B2B marketplace where users can list, license, or sell proprietary reagents, techniques, models, and IP. From premium subscriptions to institutional licensing and marketplace commissions, we’ve designed multiple revenue streams with strong margins and recurring potential.
Our pitch deck is available here.
We welcome interest from angel investors or early stage venture firms to invest into Atlantis AI360. For more information, please contact investors@atlantisai360.com.
The explosion of biomedical data and the shortage of domain-aware AI solutions have created a massive gap in life sciences R&D productivity. Atlantis AI360 fills this void with a domain-specific, auto-learning engine tailored to biotech, pharma, and healthcare. With early validation from the life sciences industry leaders as well as Wall Street firms - we are already proving our impact and positioning ourselves as the "Google + LinkedIn + GitHub" for life sciences.
Our model is built for scale. Atlantis AI360 not only offers AI-generated knowledge assets but also hosts a B2B marketplace where users can list, license, or sell proprietary reagents, techniques, models, and IP. From premium subscriptions to institutional licensing and marketplace commissions, we’ve designed multiple revenue streams with strong margins and recurring potential.
Our pitch deck is available here.
We welcome interest from angel investors or early stage venture firms to invest into Atlantis AI360. For more information, please contact investors@atlantisai360.com.
